Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|June 27, 2015
Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone lossNeng-Yu Lin, Chih-Wei Chen, Rosebeth Kagwiria, et al.
Annals of the Rheumatic Diseases|March 31, 2015
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologiesClara Dees, Christian Beyer, Alfiya Distler, et al.
Annals of the Rheumatic Diseases|April 1, 2011
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosisClara Dees, Michal Tomcik, Pawel Zerr, et al.
Leukemia|April 15, 2018
Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathwayLeonhard Busch, Dimitrios Mougiakakos, Maike Büttner-Herold, et al.
Annals of the Rheumatic Diseases|January 8, 2013
Activation of pregnane X receptor inhibits experimental dermal fibrosisChristian Beyer, Alla Skapenko, Alfiya Distler, et al.
Annals of the Rheumatic Diseases|May 24, 2013
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosisClara Dees, Inga Schlottmann, Robin Funke, et al.
Annals of the Rheumatic Diseases|November 14, 2012
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signallingAlfiya Distler, Lisa Deloch, Jingang Huang, et al.
Annals of the Rheumatic Diseases|January 22, 2014
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerabilityAlfiya Distler, Veronika Lang, Tina Del Vecchio, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1Katrin Palumbo-Zerr, Angelika Horn, Alfiya Distler, et al.
Pageof 15